Drug Access Analysis
🇪🇺 EMAExpert commentary and market intelligence for pharma strategy teams
Showing 1–2 of 2 articles
Earlier
High impact AnalysisJun 4, 2026
데일리팜 리크루트: Vyloy (zolbetuximab) Reimbursement Progress and Market Implications for Gastric Cancer
gastric cancer · 7 min
Dr. Elena RossiStandard impact AnalysisApr 21, 2026
NICE Technology Appraisals 2026: Impact on EU Pharmaceutical Market Access
NICE · Medical Devices · 10 min
Dr. Elena RossiExplore intelligence